Past Session:
37-2
37th Parliament,
2nd Session
(September 30, 2002 - November 12, 2003)
Select a different session
Meeting Detail
Study on prescription pharmaceuticals in Canada
Topic:
Witnesses
- Andrew Casey, President and Chief Executive Officer(BIOTECanada)
- Jared Rhines, Scientific and Regulatory Affairs(Rx&D)
- Walter Robinson, Vice President, Government Relations(Rx&D)
- David Windross, Vice-President of External Relations, Teva Canada(Canadian Generic Pharmaceutical Association)
Meeting with interpretation and transcription